2171 related articles for article (PubMed ID: 25412187)
1. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
[TBL] [Abstract][Full Text] [Related]
2. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
3. Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways.
Xu W; Wu W; Chen J; Guo R; Lin J; Liao X; Feng J
Int J Mol Med; 2013 Oct; 32(4):917-25. PubMed ID: 23912965
[TBL] [Abstract][Full Text] [Related]
4. ATP-sensitive K⁺ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells.
Liang W; Chen J; Mo L; Ke X; Zhang W; Zheng D; Pan W; Wu S; Feng J; Song M; Liao X
Int J Mol Med; 2016 Mar; 37(3):763-72. PubMed ID: 26820501
[TBL] [Abstract][Full Text] [Related]
5. Exogenous hydrogen sulfide protects against high glucose‑induced inflammation and cytotoxicity in H9c2 cardiac cells.
Huang Z; Dong X; Zhuang X; Hu X; Wang L; Liao X
Mol Med Rep; 2016 Nov; 14(5):4911-4917. PubMed ID: 27748941
[TBL] [Abstract][Full Text] [Related]
6. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
8. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells.
Huang Z; Zhuang X; Xie C; Hu X; Dong X; Guo Y; Li S; Liao X
Cell Physiol Biochem; 2016; 40(6):1578-1590. PubMed ID: 27997926
[TBL] [Abstract][Full Text] [Related]
9. Exogenous hydrogen sulfide ameliorates high glucose-induced myocardial injury & inflammation via the CIRP-MAPK signaling pathway in H9c2 cardiac cells.
Zhao HL; Wu BQ; Luo Y; Zhang WY; Hao YL; Liang JJ; Fang F; Liu W; Chen XH
Life Sci; 2018 Sep; 208():315-324. PubMed ID: 29857073
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells.
Chen J; Mo H; Guo R; You Q; Huang R; Wu K
Int J Mol Med; 2014 Mar; 33(3):605-12. PubMed ID: 24399619
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells.
Zhuang XD; Hu X; Long M; Dong XB; Liu DH; Liao XX
Mol Cell Biochem; 2014 Jun; 391(1-2):147-55. PubMed ID: 24687304
[TBL] [Abstract][Full Text] [Related]
12. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90/Akt pathway participates in the cardioprotective effect of exogenous hydrogen sulfide against high glucose-induced injury to H9c2 cells.
Ke X; Chen J; Peng L; Zhang W; Yang Y; Liao X; Mo L; Guo R; Feng J; Hu C; Nie R
Int J Mol Med; 2017 Apr; 39(4):1001-1010. PubMed ID: 28204829
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes.
Yang Z; Yang C; Xiao L; Liao X; Lan A; Wang X; Guo R; Chen P; Hu C; Feng J
Int J Mol Med; 2011 Sep; 28(3):397-403. PubMed ID: 21519787
[TBL] [Abstract][Full Text] [Related]
16. Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation.
Kuo WW; Wang WJ; Tsai CY; Way CL; Hsu HH; Chen LM
Int J Cardiol; 2013 Sep; 168(1):270-80. PubMed ID: 23158927
[TBL] [Abstract][Full Text] [Related]
17. Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes.
Meng YY; Liu Y; Hu ZF; Zhang Y; Ni J; Ma ZG; Liao HH; Wu QQ; Tang QZ
Curr Med Sci; 2018 Apr; 38(2):204-211. PubMed ID: 30074177
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway.
Guo C; Liang F; Shah Masood W; Yan X
Eur J Pharmacol; 2014 Feb; 725():70-8. PubMed ID: 24444438
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-κB/COX-2 pathway.
Yang C; Yang Z; Zhang M; Dong Q; Wang X; Lan A; Zeng F; Chen P; Wang C; Feng J
PLoS One; 2011; 6(7):e21971. PubMed ID: 21779360
[TBL] [Abstract][Full Text] [Related]
20. Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells.
Zhen Y; Pan W; Hu F; Wu H; Feng J; Zhang Y; Chen J
Int J Oncol; 2015 May; 46(5):2194-204. PubMed ID: 25738635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
